Michael Wood | LifeSci Advisors |
David Domzalski | Chief Executive Officer |
Matthew Wiley | Chief Commercial Officer |
Andrew Saik | Chief Financial Officer |
Carvey Leung | Cantor Fitzgerald |
David Amsellem | Piper Sandler & Co. |
Ken Cacciatore | Cowen and Company |
Patrick Dolezal | LifeSci Capital |
Good day, and welcome to the VYNE Therapeutics Third Quarter 2020 Earnings Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Mr. Michael Wood, LifeSci Advisors. Please go ahead, sir.